Pharmerica Balance Sheet - Annual (NYSE:PMC)

Add to My Stocks
$29.25 $0.05 (0.17%) PMC stock closing price Dec 07, 2017 (Closing)

The fundamental analysis of this company requires a thorough look at Pharmerica balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Pharmerica stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Pharmerica balance sheet indicates an asset turnover ratio of 1.9 and debt to equity ratio of 0.78. Also check Pharmerica revenue and Pharmerica operating cash flow for the same period.

View latest 10 year balance sheet data to check Pharmerica financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Marketable Securities---------
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets92.2M94.2M132.6M75.5M75.3M71M47.8M63.4M41.6M
Total Current Assets
Property Plant & Equipment250.9M218.5M196.4M179.5M158.8M145M136M119.6M97.1M
Accumulated Depreciation165.1M144M125M117.6M105.7M92.6M76.5M59M43.1M
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges------24.9M21M59.4M
Deposits & Other Assets81.4M34.5M4.1M9.3M12.7M14.7M5.7M2.1M3.1M
Total Assets
Notes Payable---------
Accounts Payable107.1M71.7M95.5M83.8M49.2M54.1M74.5M59.6M54.4M
Current Portion Long-Term Debt15.6M11.6M6.4M12.5M12.5M6.3M---
Current Portion Capital Leases---------
Accrued Expenses59.6M58.1M71.6M55.2M44.8M41.8M29M37.3M48.9M
Income Taxes Payable--2.3M------
Other Current Liabilities---------
Total Current Liabilities
Deferred Taxes/Income26.5M20.7M11.6M18.7M11.1M----
Convertible Debt---------
Long-Term Debt457.8M415.7M344.9M218.8M303M293.7M245.6M240M240M
Non-Current Capital Leases---------
Other Long-Term Liabilities88.7M56.5M57.7M49.9M22.5M23.7M26.4M16.5M16.1M
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus411.1M404.6M394.1M380.2M363M355.9M349.7M344.8M338.7M
Retained Earnings173.7M152.1M117M110.2M91.3M68.4M45M25.8M-16.4M
Treasury Stock40.9M37.6M33.3M28.2M12M10.8M10.6M--
Other Liabilities---------2.8M
Shareholders Equity544.2M519.4M478.1M462.5M442.6M413.8M384.4M370.9M319.8M
Total Liabilities & Shareholders Equity1.3B1.15B1.07B901.4M885.7M833.4M759.9M724.3M679.2M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Pharmerica stock price, and Pharmerica historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Pharmerica PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Pharmerica owns and has monetary significance. PMC assets grew from $1.15B in 2015 to $1.3B in 2016. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Pharmerica's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for PMC stock stand at $755.3M.

Pharmerica Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio